A provocative investigation into the approval, pricing, marketing, and misuse of prescription drugs details the often contentious relationships between pharmaceutical companies, the FDA, and doctors, citing the detriments of drug promotions while arguing for a national agenda to promote improved drug pricing and application. Reprint. 10,000 first printing.

Estimated despatch 14-20 days after ordering.